National Guideline Clearinghouse | Tocilizumab for the treatment of rheumatoid arthritis (rapid review of technology appraisal guidance 198).

full-text:
National Guideline Clearinghouse | Tocilizumab for the treatment of rheumatoid arthritis (rapid review of technology appraisal guidance 198).

Guideline Title

Tocilizumab for the treatment of rheumatoid arthritis (rapid review of technology appraisal guidance 198).

 

 

Bibliographic Source(s)

National Institute for Health and Clinical Excellence (NICE). Tocilizumab for the treatment of rheumatoid arthritis. London (UK): National Institute for Health and Clinical Excellence (NICE); 2012 Feb. 55 p. (Technology appraisal guidance; no. 247).

 

 

Guideline Status

This is the current release of the guideline.
This guideline updates a previous version: National Institute for Health and Clinical Excellence (NICE). Tocilizumab for the treatment of rheumatoid arthritis. London (UK): National Institute for Health and Clinical Excellence (NICE); 2010 Aug. 50 p. (Technology appraisal guidance; no. 198).